Navigation Links
Tongjitang Files 2009 Annual Report on Form 20-F
Date:7/1/2010

ed in Shenzhen, China.

Tongjitang's flagship product, Xianling Gubao, is the leading traditional Chinese medicine for the treatment of osteoporosis in China as measured by sales in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets 36 other modernized traditional Chinese medicine products and 37 western medicines. Please visit http://www.tongjitang.com for more information.

    For further information, please contact:

    ICR, Inc.
     Ashley M. Ammon or Christine Duan
     Tel: +1-203-682-8200 (Investor Relations)


'/>"/>
SOURCE Tongjitang Chinese Medicines Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
2. Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
5. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
6. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
9. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
10. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
11. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. ... Biotechnology, Inc. for the compounding, packaging and distributing of its ... the United States . ... of compounding naltrexone tablets in various strengths for individual patients ...
(Date:1/23/2015)... 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself as ... and grab a foothold in the hydroponic, hemp and medical ... a presence in the sector, and recently partnering with the ... hemp and medical marijuana, iMD is committing to bring its ...
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... - 12-week study concludes that new cosmeceutical improves skin ... Calif., May 4 Senetek PLC (OTC ... the development of technologies that target the science of ... "Topical PRK-124 (0.125%) Lotion for Improving the Signs and ...
... Experience Significant Improvement in Ocular Surface Disease and Quality ... Inc. announced today that results from a large (n ... ophthalmic insert will be presented this week during the ... Vision and Ophthalmology (ARVO), May 3-7, Ft. Lauderdale, FL, ...
Cached Medicine Technology:Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 3ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 4ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 5
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
(Date:1/22/2015)... released a new blog post presenting a list of vehicles that ... , Some types of vehicles cannot be covered under an ordinary ... to see if their vehicle qualifies for auto insurance coverage. ... cars that cannot be covered by a plan. Clients have little ...
(Date:1/22/2015)... VA (PRWEB) January 22, 2015 Step ... power at the Science Museum of Virginia. Wicked Plants, ... , Wicked Plants unearths 75 poisonous, carnivorous and diabolical ... through each room to uncover the biochemical, physical and ...
(Date:12/26/2014)... The US represents the largest market for CRC across ... estimates that sales of branded therapies were $2.23 billion. The ... incidence of the disease, high drug treatment rate, and higher ... sales of CRC therapies over the forecast period will be ...
Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Executive Director, Campaign for,Tobacco-Free Kids, WASHINGTON, July ... a truly historic vote to protect children from,tobacco ... the U.S. Food and Drug Administration authority to ... House has ever approved such,legislation. Today,s vote by ...
... SAN DIEGO, July 30 BioMed Realty Trust, Inc.,(NYSE: BMR ... the life science industry, today announced financial results for,the second quarter ... operations (FFO) for the quarter were $34.5 million, or ... transactions during the quarter representing gross leasing ...
... Record High, BEDFORD, Mass., July 30 ... technologies company specializing in,diagnostics, imaging products and interventional ... today announced its results for the,quarter ended June ... -- Revenues of $429.5 million., -- ...
... DOVER, N.H., July 30 The U.S. House of,Representatives ... grant the U.S. Food and Drug Administration (FDA) authority ... tobacco,marketing and sales to kids. The bill passed with ... goes to the U.S. Senate for,consideration. Senator Judd Gregg ...
... ATLANTA, July 30 J.D. Power and Associates,announced ... Member,Satisfaction among Commercial Health Plans in the South ... Plan Study(SM)., This is the first J.D. ... The J.D. Power and Associates study evaluated seven ...
... it promotes growth of healthy tissue after heart attack , , ... to regenerate cardiac muscle damaged by a heart attack or ... human trials. , The patch is made of vicryl, a ... by the body, explained Jordan J. Lancaster, a predoctoral fellow ...
Cached Medicine News:Health News:U.S. House Casts Historic Vote to Protect Kids from Tobacco, Save Lives; Senate Should Act This Year and President Should Sign Bill Into Law 2Health News:U.S. House Casts Historic Vote to Protect Kids from Tobacco, Save Lives; Senate Should Act This Year and President Should Sign Bill Into Law 3Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 2Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 3Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 4Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 5Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 6Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 7Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 8Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 9Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 10Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 11Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 12Health News:BioMed Realty Trust Reports Second Quarter 2008 Financial Results 13Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 2Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 3Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 4Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 5Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 6Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 7Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 8Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 9Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 10Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 11Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 12Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 13Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 14Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 15Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 16Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 17Health News:Hologic Announces Third Quarter Fiscal 2008 Operating Results 18Health News:House Passes Historic Bill to Protect Kids From Tobacco; Senator Sununu Should Cosponsor Legislation 2Health News:J.D. Power and Associates Study Ranks Kaiser Permanente Highest in Member Satisfaction in South Atlantic Region 2Health News:Patch Helps Mend Damaged Hearts 2
Size: Medium. 22.50 mm by 24.00 mm. Clear lucite. Supplied sterile....
... 3.0 x 7.5 x 80 mm. ... II line designed by Harvey A. ... a closed cell sponge which is ... with rounded edges to minimize scleral ...
... x 7.5 x 80 mm. Storz ... line designed by Harvey A. Lincoff, ... closed cell sponge which is non-toxic ... rounded edges to minimize scleral intrusion. ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
Medicine Products: